CareMax — Q4 2021 Earnings Presentation
15 slides from CareMax's earnings presentation, Mar 8, 2022
Slide 1: Fourth Quarter and Full Year 2021 Earnings Presentation
Fourth Quarter and Full Year 2021 Earnings Presentation March 8, 2022 EX-99.2
Slide 2: Disclaimer
Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or
Slide 3: CareMax at a Glance
CareMax at a Glance 33K+ Medicare Advantage Members 2011 Year Founded 48 Medical Centers1 100+ Employed Providers 83K+ Total Members We are… A founder-led, technology-enabled, whole person healthcare platform providing value-based care and chronic disease management to seniors. Our mission… Is to em
Slide 4: Fourth Quarter 2021 Update
Fourth Quarter 2021 Update Reported revenue of $118M for 4Q21, of which 94% was risk-based revenue Achieved a 71.5% Medical Expense Ratio for 4Q21, an improvement of ~400 basis points from 3Q21 Captured previously announced combination synergies with IMC, driven by medical management, SG&A savings,
Slide 5: Continued Growth in Medical Center Footprint and Medicare Advantage Membership
We Expect Continued Growth in Our Medical Center Footprint and Medicare Advantage Membership Medical Centers as of Year End Medicare Advantage Members as of Year End 10x ~13x
Slide 6: Our Differentiated Care Model Has Mitigated COVID Admissions Among Our Members
Our Differentiated Care Model Has Mitigated COVID Admissions Among Our Members COVID Admissions Remain Under Control1 In-Person PCP Visits Have Rebounded over 20201 We have experienced lower COVID-19 admissions quarter-to-date through February than during the previous wave in July and August 2021 In
Slide 7: Financial Outlook for Full Year 2022
Financial Outlook for Full Year 2022 FY 2022 Guidance YoY % growth Medicare Advantage Membership 38,000 to 40,000 13% to 19% Revenue $540 million to $560 million 34% to 39%1 Adjusted EBITDA $30 million to $40 million 125% to 200%1 Year-End Center Count 60 (15 openings) 33% Compared to pro forma 2021
Slide 8: Fourth Quarter 2021 Financial Supplement
Fourth Quarter 2021 Financial Supplement
Slide 9: Reconciliation to Non-GAAP Financial Metrics
Reconciliation to Non-GAAP Financial Metrics Reflects impact of business combination of CareMax, IMC, and Care Holdings and other pro forma adjustments as may arise from the combination. 4Q21 Non-GAAP Reconciliation 4Q20 Non-GAAP Reconciliation 1 1
Slide 10: Reconciliation to COVID-Adjusted Medical Expense Ratio
Reconciliation to COVID-Adjusted Medical Expense Ratio Estimated impact from COVID restrictions affecting our ability to appropriate assess and document members’ health conditions in 2020, resulting in an impact to Medicare risk reimbursement rates in 2021. Claims expenses directly associated with i
Slide 11: Reconciliation to 2021 Pro Forma Run-Rate Revenue and Adjusted EBITDA
Reconciliation to 2021 Pro Forma Run-Rate Revenue and Adjusted EBITDA Reflects revenue PMPM rates exiting the year applied to year-end membership, including run-rate contribution from tuck-in acquisitions closed and health plan members assigned. Reflects estimated incremental run-rate contributions
Slide 12: Historical Non-GAAP Financial Summary
Historical Non-GAAP Financial Summary Note: Figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Totals may not sum due to rounding. Includes operating losses incurred by de novo centers up to 18 months after opening. Non-GAAP Inco
Slide 13: Reconciliation to Adjusted EBITDA
Reconciliation to Adjusted EBITDA Note: Pro forma and non-GAAP figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods (the “Business Combination”). Totals may not sum due to rounding. Pro forma net income replaces historical interest
Slide 14: Capitalization and Liquidity
Capitalization and Liquidity Excludes unvested warrants. Warrants have a strike price of $11.50/share and (other than the Related warrants) are subject to a $18.00 redemption cap. Warrants are currently out of the money based on CareMax’s closing share price as of March 7, 2022. 50% of earnout share
Slide 15: Q&A
Caremax Q&A